Evidence map›Paper›PMID 36101375›Full record

ArticleBiology2022

The Preyssler-Type Polyoxotungstate Exhibits Anti-Quorum Sensing, Antibiofilm, and Antiviral Activities.

Leonor Faleiro, Ana Marques, João Martins, Luísa Jordão, Isabel Nogueira, Nadiia I Gumerova, Annette Rompel, Manuel Aureliano

Open access · goldAbstract read
In one paragraph

Article in Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Peroxo-Containing Heteropolyanions [{XWInorganic chemistry · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Polyoxometalates Impact as Anticancer Agents.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Leonor FaleiroFaculdade de Ciências e Tecnologia, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.ORCID 0000-0002-3878-6948
Ana MarquesFaculdade de Ciências e Tecnologia, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.
João MartinsFaculdade de Ciências e Tecnologia, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.
Luísa JordãoDepartamento de Saúde Ambiental (DSA), Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA), Unidade de Investigação e Desenvolvimento, 1649-016 Lisboa, Portugal.ORCID 0000-0002-5608-021X
Isabel NogueiraMicroLab, Instituto Superior Técnico, Avenida Rovisco Pais, 1049-001 Lisboa, Portugal.ORCID 0000-0002-6138-1172
Nadiia I GumerovaUniversität Wien, Fakultät für Chemie, Institut für Biophysikalische Chemie, 1090 Wien, Austria.ORCID 0000-0003-4375-0103
Annette RompelUniversität Wien, Fakultät für Chemie, Institut für Biophysikalische Chemie, 1090 Wien, Austria.ORCID 0000-0002-5919-0553
Manuel AurelianoFaculdade de Ciências e Tecnologia, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.ORCID 0000-0003-4858-3201
University of Algarve · PTUniversity of Vienna · ATAlgarve Biomedical Center · PTChampalimaud Foundation · PTInstituto Superior Técnico · PTNational Institute of Health Dr. Ricardo Jorge · PT

Funding

Austrian Science Fund FWF P 33089Austrian Science Fund FWF P 33927Austrian Science Fund; University of Vienna (N.G. and A.R.) P33927 (N.G.); P33089 (A.R.)Fundação para a Ciência e Tecnologia UIDB/04326/2020 (M.A.) and LA/P/0101/2020
6 · The paper itself

Abstract

The increase in bacterial resistance to antibiotics has led researchers to find new compounds or find combinations between different compounds with potential antibacterial action and with the ability to prevent the development of antibiotic resistance. Polyoxotungstates (POTs) are inorganic clusters that may fulfill that need, either individually or in combination with antibiotics. Herein, we report the ability of the polyoxotungstates (POTs) with Wells-Dawson P2W18, P2W17, P2W15, and Preyssler P5W30 type structures to differently affect Gram-negative and Gram-positive microorganisms, either susceptible or resistant to antibiotics. The compound P5W30 showed the highest activity against the majority of the tested bacterial strains in comparison with the other tested POTs (P2W15, P2W17 and P2W18) that did not show inhibition zones for the Gram-negative bacteria, A. baumanii I73775, E. coli DSM 1077, E. coli I73194, K. pneumoniae I7092374, and P. aeruginosa C46281). Generally, the results evidenced that Gram-positive bacteria are more susceptible to the POTs tested. The compound P5W30 was the one most active against S. aureus ATCC 6538 and MRSA16, reaching <0.83 mg·mL−1 (100 μM) and 4.96 mg·mL−1 (600 μM), respectively. Moreover, it was verified by NMR spectroscopy that the most promising POT, P5W30, remains intact under all the experimental conditions, after 24 h at 37 °C. This prompted us to further evaluate the anti-quorum sensing activity of P5W30 using the biosensor Chromobacterium violaceum CV026, as well as its antibiofilm activity both individually and in combination with the antibiotic cefoxitin against the methicillin-resistant Staphylococcus aureus 16 (MRSA16). P5W30 showed a synergistic antibacterial effect with the antibiotic cefoxitin and chloramphenicol against MRSA16. Moreover, the antibiofilm activity of P5W30 was more pronounced when used individually, in comparison with the combination with the antibiotic cefoxitin. Finally, the antiviral activity of P5W30 was tested using the coliphage Qβ, showing a dose-dependent response. The maximum inactivation was observed at 750 μM (6.23 mg·mL−1). In sum, P5W30 shows anti-quorum sensing and antibiofilm activities besides being a potent antibacterial agent against S. aureus and to exhibit antiviral activities against enteric viruses.

Indexed as

antibacterial drugsantibiotic resistancebacterial resistancemultiresistantP2W18P5W30Wells-Dawson polyoxometalates

Identifiers

PMID36101375
PMCPMC9311568
OpenAlexW4283757036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.